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Informed shared decision-making between patients and health care providers can be
facilitated by the use of patient decision aids (PDAs). PDAs are tools that provide
evidence-based treatment options and clarify patient values and preferences. Prior to this
research, no PDA existed for hidradenitis suppurativa (HS), a complex dermatological
condition. Thus, the objectives of this research were to (1) develop a PDA for HS with
input from patients and physicians, and (2) conduct a randomized controlled trial (RCT)
to test its effectiveness during treatment decision-making compared to the Mayo Clinic
HS website.
The PDA was developed in accordance with International Patient Decision Aid
Standards. Its content was based on the North American Clinical Management Guidelines
for HS and reviewed by 3 dermatologists and 2 patient representatives prior to being
transformed into an online PDA. Feedback on PDA content and presentation was
obtained from 7 HS patients who are members of the online support group Hope for HS.
All indicated that the treatment options included in the PDA contained the appropriate
amount of information, and most (71%, n=5/7) found it helpful to see these options
compared to their values. At the end of the PDA, all but one stated they were either ready
or very ready to make a treatment decision. All indicated that they would recommend the
PDA to their friends and family with HS. 5 physicians across North America provided
feedback on PDA content, presentation, and applicability to practice. The majority (60%,
n=3/5) agreed that the content was accurate and that the amount of detail was appropriate.
Most (80%, n=4/5) also agreed that the language was patient-friendly. All but one
indicated that they would recommend patients use the PDA and bring their Patient
Summary Page to their next appointment.
The participant blinded, parallel group RCT was conducted online with HS patients from
the online support groups HS Warriors for Research and Hope for HS. 21 and 20
participants were randomized to the PDA and Mayo Clinic group, respectively. 15 and 13
participants in the PDA and Mayo Clinic group, respectively, fully completed the RCT,
and only their data was assessed. The PDA group showed significantly improved levels
of knowledge, lower levels of decisional conflict, and increased levels of preparedness
for decision-making compared to the Mayo Clinic group.
The HS PDA received positive feedback from both patients and physicians. It was also
shown to improve patient knowledge, reduce decisional conflict, and increase
preparedness for decision-making. It is available at www.informed-decisions.org and is
free to use. Detailed findings of this research will be submitted for inclusion in an
academic journal.

